Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

Spoiler alert! We're talking aboutthe biggest reveals in "Backrooms" (in theaters now) and the movie's ending, so turn away if you haven't seen it yet. The world of "Backrooms" isn't done expanding.

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. Credit: A24 Dark closets ...

After months of anticipation, Backrooms is finally playing in cinemas, taking horror fans and other viewers into the seemingly endless - and slightly unnerving - void of liminal spaces. The film, ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the 10 Best Penny Stocks to Buy for Long Term. On May 14, 2026, Morgan Stanley raised the firm’s price target on Recursion Pharmaceuticals, Inc.

Be careful what you wish for. This idea, often explored in fiction, lies at the center of “Obsession,” Focus Features‘ new horror film from writer/director/editor Curry Barker. The movie follows Bear ...

More stories by Kevin P. After nearly 12 years, eight seasons, and 101 episodes, the mystical, magical love story of Claire and Jamie Fraser has come to an end. Or has it? Yes. But it's understandable ...

The final episode of Outlander dropped on the Starz app last night and now we finally know how Jamie (Sam Heughan) and Claire’s (Caitriona Balfe) epic love story ends. **Spoilers for Outlander Season ...

Warning! Spoilers ahead for Obsession. Although the movie is filled with dark and disturbing moments, the last shot of Obsession leaves viewers with an image that’s almost unbelievably bleak. After ...

"For 2026, we are maintaining our cash operating expense guidance of less than $390 million." (CFO & President of Recursion UK Taylor). "We expect multiple clinical readouts over the next 12 to 18 ...